Literature DB >> 8759073

Determinants of increased regional left atrial coagulation activity in patients with mitral stenosis.

R E Peverill1, R W Harper, J Gelman, T E Gan, G Harris, J J Smolich.   

Abstract

BACKGROUND: Recent evidence suggests that regional left atrial coagulation activity may be increased in mitral stenosis and perhaps contribute to the pathophysiology of left atrial thrombus. However, the relation of left atrial coagulation activity to factors that predispose to left atrial thrombus formation is unknown, and the relation between left atrial and systemic coagulation activities is unresolved. METHODS AND
RESULTS: Left atrial and peripheral venous levels of the coagulation marker prothrombin fragment 1 + 2 (F1 + 2) were measured in 32 patients with mitral stenosis with normal clotting times and no left atrial thrombus who were undergoing percutaneous balloon mitral valvuloplasty. Baseline peripheral venous F1 + 2 levels, measured at the beginning of the valvuloplasty procedure, did not differ from those of 30 age-matched control patients. Prevalvuloplasty left atrial F1 + 2 levels, obtained immediately after transseptal puncture, were similar to femoral venous levels in patients without left atrial spontaneous echo contrast (LASEC) (0.81 +/- 0.32 versus 0.81 +/- 0.27 nmol/L, n = 7) but greater than femoral venous levels in patients with LASEC and either sinus rhythm (1.57 +/- 0.86 versus 0.99 +/- 0.38 nmol/L, n = 16, P < .001) or atrial fibrillation (1.52 +/- 0.69 versus 0.85 +/- 0.33 nmol/L, n = 9, P < .003). Furthermore, LASEC emerged as the only significant predictor of increased regional left atrial coagulation activity (P = .005) on stepwise multivariate logistic regression analysis.
CONCLUSIONS: Increased regional left atrial coagulation activity in mitral stenosis occurs in the presence of LASEC, is evident in either sinus rhythm or atrial fibrillation, and is associated with normal systemic coagulation activity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8759073     DOI: 10.1161/01.cir.94.3.331

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  9 in total

1.  Prevention of thromboembolism in atrial fibrillation. A meta-analysis of trials of anticoagulants and antiplatelet drugs.

Authors:  J B Segal; R L McNamara; M R Miller; N Kim; S N Goodman; N R Powe; K A Robinson; E B Bass
Journal:  J Gen Intern Med       Date:  2000-01       Impact factor: 5.128

2.  Evaluation of left atrial appendage functions in patients with thrombus and spontaneous echo contrast in left atrial appendage by using color Doppler tissue imaging.

Authors:  Ramazan Topsakal; Namik Kemal Eryol; Yüksel Ciçek; Hayrettin Sağlam; Ergün Seyfeli; Adnan Abaci; Abdurrahman Oğuzhan; Ali Ergin; Emrullah Başar
Journal:  Ann Noninvasive Electrocardiol       Date:  2004-10       Impact factor: 1.468

3.  Hypercoagulability and haemodynamic abnormalities in atrial fibrillation.

Authors:  G Y Lip
Journal:  Heart       Date:  1997-05       Impact factor: 5.994

4.  Effect of heart rate control on coagulation status in patients of rheumatic mitral stenosis with atrial fibrillation--A pilot study.

Authors:  Jamal Yusuf; Mayank Goyal; Saibal Mukhopadhyay; Vimal Mehta; Sunil Dhaiya; Renu Saxena; Vijay Trehan
Journal:  Indian Heart J       Date:  2015-11-23

Review 5.  Antithrombotic therapy for valve disease: native and prosthetic valves.

Authors:  A M Al-Ahmad; D H Daudelin; D N Salem
Journal:  Curr Cardiol Rep       Date:  2000-01       Impact factor: 2.931

6.  Rheumatic Heart Disease Predisposing to Embolic Myocardial Infarction: A Multimodality Imaging Approach.

Authors:  Emanuele Canali; Giuseppe Cannavale; Giulia Conti; Simona Mariani; Fabrizio Proietti
Journal:  Int J Angiol       Date:  2013-07-23

7.  Impaired fibrinolytic capacity in rheumatic mitral stenosis with or without atrial fibrillation and nonrheumatic atrial fibrillation.

Authors:  Enver Atalar; Ferhan Ozmen; Ibrahim Haznedaroğlu; Necla Ozer; Serdar Aksöyek; Kenan Ovünç; Nasih Nazli; Serafettin Kirazli; Sirri Kes
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

8.  Presence of factors that activate platelet aggregation in mitral stenotic patients' plasma.

Authors:  Istemihan Tengiz; Ertugrul Ercan; Fahri Sahin; Emin Alioglu; Can Duman; Guray Saydam; Filiz Buyukkececi
Journal:  Curr Control Trials Cardiovasc Med       Date:  2005-02-27

9.  Non-vitamin K antagonist oral anticoagulants versus warfarin for the prevention of spontaneous echo-contrast and thrombus in patients with atrial fibrillation or flutter undergoing cardioversion: A trans-esophageal echocardiography study.

Authors:  Yun Gi Kim; Jong-Il Choi; Mi-Na Kim; Dong-Hyuk Cho; Suk-Kyu Oh; Hyungdon Kook; Hee-Soon Park; Kwang No Lee; Yong-Soo Baek; Seung-Young Roh; Jaemin Shim; Seong-Mi Park; Wan Joo Shim; Young-Hoon Kim
Journal:  PLoS One       Date:  2018-01-23       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.